evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/geneAliases/4,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract,articles/11/pmid,articles/11/title,articles/11/journal,articles/11/pubDate,articles/11/volume,articles/11/issue,articles/11/pages,articles/11/authors,articles/11/elocationId,articles/11/link,articles/11/reference,articles/11/abstract
13357,GENE_BACKGROUND,,"U2AF1 (U2 small nuclear RNA auxiliary factor 1) encodes the splicing factor subunit protein, U2AF35, which together with its binding partner, U2AF65, regulate removal of introns from pre-mRNAs to produce mature mRNAs that will be translated during protein synthesis (PMID:1388271). The U2AF1 protein is essential for constitutive and enhancer-dependent splicing since it recruits the whole U2AF complex to the 3' end of the pre-mRNA intron that will be spliced (PMID: 8647433, 10617206, 10617208). Mutations in the U2AF1 gene have been found recurrently similarly in hematological malignancies such as myelodysplastic syndromes (MDS) (PMID:22389253) and Acute Myeloid Leukemia (AML) (PMID: 22158538) or Chronic Myelomonocytic leukemia (CMML) (PMID: 22323480). Interestingly it has been proposed that mutations in RNA splicing genes are drivers of the transition from MDS to different sort of myeloid leukemias (PMID:24030381). Therefore, the U2AF1 protein has been proposed as a potential therapeutic target (PMID: 21909114, 22158538, 22323480, 25965570, 25326705). Importantly, it has been shown that mutations in the U2AF1 gene happen early in leukemia development as it has been shown in secondary acute myeloid leukemia (s-AML) and can persist during disease progression (PMID:25550361).",,2017-04-05,,7307,U2AF1,U2 small nuclear RNA auxiliary factor 1,True,ENST00000291552,NM_006758.2,FP793,U2AFBP,RN,RNU2AF1,U2AF35,False,8647433,The splicing factor U2AF35 mediates critical protein-protein interactions in constitutive and enhancer-dependent splicing.,Genes &amp; development,0001-06-01,10,11,1356-68,Zuo P et al,,,0001-06-01,,25550361,Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.,Blood,2018-02-26T20:15:00,125,9,1367-76,Lindsley RC et al,doi: 10.1182/blood-2014-11-610543,,0001-02-26,,10617208,Inhibition of msl-2 splicing by Sex-lethal reveals interaction between U2AF35 and the 3' splice site AG.,Nature,0001-12-16,402,6763,838-41,Merendino L et al,,,0001-12-16,,25965570,Mutant U2AF1 Expression Alters Hematopoiesis and Pre-mRNA Splicing In Vivo.,Cancer cell,2018-05-11T20:15:00,27,5,631-43,Shirai CL et al,doi: 10.1016/j.ccell.2015.04.008,,0001-05-11,,10617206,Functional recognition of the 3' splice site AG by the splicing factor U2AF35.,Nature,0001-12-16,402,6763,832-5,Wu S et al,,,0001-12-16,,1388271,Cloning and intracellular localization of the U2 small nuclear ribonucleoprotein auxiliary factor small subunit.,Proceedings of the National Academy of Sciences of the United States of America,0001-09-15,89,18,8769-73,Zhang M et al,,,0001-09-15,,22389253,"Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes.",Blood,2018-04-12T20:12:00,119,15,3578-84,Thol F et al,doi: 10.1182/blood-2011-12-399337,,0001-04-12,,21909114,Frequent pathway mutations of splicing machinery in myelodysplasia.,Nature,2018-09-11T20:11:00,478,7367,1964-09-01,Yoshida K et al,doi: 10.1038/nature10496,,0001-09-11,,24030381,Clinical and biological implications of driver mutations in myelodysplastic syndromes.,Blood,2017-11-21T20:13:00,122,22,3616-27; quiz 3699,Papaemmanuil E et al,doi: 10.1182/blood-2013-08-518886,,0001-11-21,,25326705,Mechanisms for U2AF to define 3' splice sites and regulate alternative splicing in the human genome.,Nature structural &amp; molecular biology,2018-11-01T20:14:00,21,11,997-1005,Shao C et al,doi: 10.1038/nsmb.2906,,2018-11-01T10:05:00,,22158538,Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes.,Nature genetics,2017-12-11T20:11:00,44,True,1953-07-01,Graubert TA et al,doi: 10.1038/ng.1031,,0001-12-11,,22323480,"Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis.",Blood,2018-04-05T20:12:00,119,14,3203-10,Makishima H et al,doi: 10.1182/blood-2011-12-399774,,0001-04-05,
13356,GENE_SUMMARY,,U2AF1 encodes a splicing regulation component involved in the processing of messenger RNA (mRNA) into mature RNA containing only codifying exons. U2AF1 has been found recurrently mutated in hematologic malignancies.,,2017-04-05,,7307,U2AF1,U2 small nuclear RNA auxiliary factor 1,True,ENST00000291552,NM_006758.2,FP793,U2AFBP,RN,RNU2AF1,U2AF35,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
